Bayer's U.S. patent related to glucosinolate transporters is U.S. Patent No. 10,683,454 [1]. This patent covers specific glucosinolate transporter genes, constructs, and methods of use, particularly in modifying plant traits [1].
How are glucosinolate transporters used in plants?
Glucosinolate transporters play a role in the movement of glucosinolates within plants. Modifying these transporters can alter the levels and distribution of glucosinolates, which are sulfur-containing compounds that can influence plant defense mechanisms and nutritional value [1]. Bayer's patent focuses on utilizing these transporters to modify plant characteristics, potentially for agricultural applications [1].
When does Bayer's U.S. Patent 10,683,454 expire?
U.S. Patent No. 10,683,454 is set to expire on October 12, 2038 [1]. This expiration date is crucial for understanding when the technology it covers may become available for generic or biosimilar development, depending on the specific claims and regulatory pathways.
What is the significance of glucosinolate transporter patents?
Patents on genes and technologies like glucosinolate transporters are significant for companies like Bayer as they grant exclusive rights to use, sell, and develop products based on that patented technology for a specific period [1]. This exclusivity can influence research and development, market entry strategies for new crop varieties, and potentially impact the agricultural sector by controlling access to specific genetic modifications [1].
Where can I find more information on drug and patent expirations?
For comprehensive data and analysis on patent expirations, including those related to agricultural technologies and pharmaceuticals, DrugPatentWatch.com provides extensive resources and databases [2].
Sources
1. U.S. Patent No. 10,683,454
2. https://drugpatentwatch.com